A genome is an organism's complete set of DNA, including all of its genes. Each genome contains all of the information needed to build and maintain that organism.
MARKET DYNAMICS
The genome-based drug market is driving due to the Factors such as the rising government funding and growth in the number of genomics projects, decreasing sequencing costs, growing application areas of genomics, and the entry of new players and start-ups in the genomics field. However, the high cost of genomic equipment could limit market growth to a certain extent in the coming years.
MARKET SCOPE
The "Genome-Based Drug Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of genome-based drug market with detailed market segmentation by application, and end-user. The genome-based drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in genome-based drug market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The genome-based drug market is segmented on the basis of application, and end-user. Based on application, the market is segmented into oncology, cardiovascular, metabolic and rare diseases. On the basis of end-user, the market is segmented into research centers, academic & government institutes, pharmaceutical & biotechnology companies and other end users.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the genome-based drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The genome-based drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting genome-based drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the genome-based drug market in these regions.
MARKET PLAYERS
The report covers key developments in the genome-based drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from genome-based drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for genome-based drug in the global market. Below mentioned is the list of few companies engaged in the genome-based drug market.
The report also includes the profiles of key players in genome-based drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Illumina, Inc.
- Thermo Fisher Scientific
- Qiagen
- Eurofins Scientific
- Agilent Technologies
- Oxford Nanopore Technologies
- F. Hoffmann-La Roche
- Bio-Rad Laboratories
- BGI
- Danaher Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.